RSSL Launches new training course to meet rising demand of ATMPs

As the growing demand for personalised medicines continues, a recent report projects that the global growth of the Advanced Therapy Medical Products (ATMPs) market will also be boosted.

This creates tremendous potential for patients and the industry alike.

Currently there are a small number of licensed products, with many more undergoing clinical trials. In addition to this, there are numerous projects in late phase development about to enter the clinical trial phase.

Current guidance has struggled to keep up with the rapid expansion of this area of product development in the Pharmaceutical arena. As companies move from the bench to requiring to needing authorised premises, they will be inspected by the Regulatory Authority and are likely to experience issues if they have not understood the applicable GMPs for ATMPs.

There is therefore a need for practical GMP guidance for these products and sharing of experiences.
RSSL has recognised this need and has created a training course perfectly suited to both those new to the field and those that have been working in the field for some time but have little understanding of the GMP expectations for this group of products.

RSSL's Good Manufacturing Practice for ATMPS course is designed to help attendees understand what ATMPs are, raise awareness of the legislation and guidelines, understand practical GMP challenges as well as gain awareness of this specialised area of development and manufacture.

One Nucleus Members can receive 20% off the cost of this course when they place their booking by 29 February.
Please contact RSSL via to obtain the discount code that can be applied when booking.
This discount code cannot be used in conjunction with any other offer.

Media Contact Information: 

To learn more about this course and book for place, please visit: